Closing the genetic testing gap in cardiovascular disease
The gap between guidelines and practice
Genetic testing is guideline-recommended for patients with cardiomyopathy and channelopathies. In practice, fewer than 1% receive it 12. Cost, access, and workflow barriers keep testing out of reach for most patients and most providers.
Heartgene removes these barriers: no cost to patients or providers, clinical-grade sequencing, expert interpretation, and integrated genetic counseling.
No cost to patients
No insurance required
No billing to providers
How Heartgene works
From eligibility to results, without cost, insurance, or a lab visit.
Qualify & order
Patients with a qualifying condition or first-degree relatives of patients who tested positive at Heartgene, complete a short eligibility check. A sample kit is mailed to their home.
Sequence &
interpret
Broad Clinical Labs sequences 57 cardiovascular genes. Variants are interpreted by Mass General Brigham LMM per ACMG/AMP standards.
Results & action
Providers receive a clinical report with care pathway recommendations. Patients receive a plain-language summary. Positive results include no-cost genetic counseling.
Clinical infrastructure
Every Heartgene test is backed by clinical-grade laboratory partners.
Leadership
Heartgene is led by a team with expertise in clinical genomics, genetic counseling, and healthcare operations.
